Lepu likita COVID-19 antigen gwajin gaggawar gwajin AMRDT106

Cikakken Bayani

Samfurin shirye-shiryen na iya ɗauka bisa ga matakan aiki.
1.Specimen hakar reagent
2.Bari swab a cikin bututun reagent na minti daya.
3.Cinci bututun hakar da yatsu.
4.Saka bututun ƙarfe.

Marufi & Bayarwa

Ƙayyadaddun bayanai

Lepu likita COVID-19 antigen gwajin gaggawar gwajin AMRDT106

Abubuwan da aka gano sun haɗa da swab na nasopharyngeal da swab na oropharyngeal.

Lepu likita COVID-19 na'urar gwajin sauri na antigen AMRDT106 Ƙayyadaddun bayanai
COVID-19 Antigen Rapid Test Cassette AMRDT106:
Ganewar Protein Nucleocapsid SARS-CoV-2:

Nucleocapsid (N) furotin shine mafi yawan furotin tare da kiyaye shi sosai a cikin SARS-CoV-2.
Ana amfani da furotin N azaman ainihin albarkatun ƙasa na saurin gano maganin rigakafi a cikin kasuwa.

COVID-19 Antigen Rapid Test Cassette Wanda Clongene ya Haɓaka:
Clongene ya haɓaka kaset ɗin gwajin gaggawa na Antigen na COVID-19. The colloidal gold immunoassay
(CGIA) don gano furotin nucleocapsid na SARS-CoV-2 ya dogara ne akan ka'idar fasahar rigakafin mutum-sandi.

Lepu likita COVID-19 na'urar gwajin saurin antigen AMRDT106 AMRDT106 NUFIN AMFANI:

The COVID-19 Antigen Rapid Cassette shine gwajin gwajin jini na gefe wanda aka yi niyya don gano ingantattun antigens SARS-CoV-2 nucleocapsid a cikin swab na nasopharyngeal da swab na oropharyngeal daga mutanen da ake zargin CoVID-19 ta hanyar mai ba da lafiyar su. Sakamako shine don ganewa. na SARS-CoV-2 nucleocapsid antigen.Antigen gabaɗaya ana iya gano shi a cikin swab na nasopharyngeal da swab na oropharyngeal a lokacin matsanancin lokaci na kamuwa da cuta.

Sakamakon sakamako mai kyau yana nuna kasancewar antigens na kwayar cutar, amma haɗin gwiwar asibiti tare da tarihin haƙuri da sauran bayanan bincike ya zama dole don sanin matsayin kamuwa da cuta.Sakamako mai kyau ba zai kawar da kamuwa da kwayar cutar ba ko kamuwa da cuta tare da wasu ƙwayoyin cuta.Wakilin da aka gano bazai zama tabbatacce ba. sakamakon cutar.Sakamako mara kyau baya kawar da kamuwa da cutar SARS-CoV-2 kuma bai kamata a yi amfani da shi azaman tushen kawai don magani ko yanke shawara na kulawa da haƙuri ba, gami da yanke shawarar sarrafa kamuwa da cuta.

Ya kamata a yi la'akari da sakamako mara kyau a cikin mahallin bayyanar majiyyaci kwanan nan, tarihi da kasancewar alamun asibiti da alamun da suka dace da COVID-19, kuma an tabbatar da su tare da gwajin ƙwayoyin cuta, idan ya cancanta don sarrafa haƙuri.CoVID-19 Antigen Rapid Test Cassette an yi niyya don amfani da ƙwararrun ma'aikatan dakin gwaje-gwaje na asibiti musamman waɗanda aka ba da umarni da kuma horar da hanyoyin bincike na vitro.

Lepu likita COVID-19 na'urar gwajin saurin antigen AMRDT106 Samfura:
Abubuwan da aka gano sun haɗa da swab na nasopharyngeal da swab na oropharyngeal.
Samfurin shirye-shiryen na iya ɗauka bisa ga matakan aiki.
1.Specimen hakar reagent
2.Bari swab a cikin bututun reagent na minti daya.
3.Cinci bututun hakar da yatsu.
4.Saka bututun ƙarfe.

Lepu likita COVID-19 na'urar gwajin sauri na antigen AMRDT106 KYAUTA:
Kaset ɗin gwajin yana ƙunshe da tsiri mai laushi wanda aka lulluɓe da anti-SARS-CoV-2 nuclenocapsid protein monoclonal antibody akan layin gwajin T, da kushin rini wanda ya ƙunshi zinare colloidal haɗe da SARS-CoV-2 nuclenocapsid protein monoclonal antibody.